The global EPA & DHA omega-3 market is undergoing rapid transformation as companies intensify innovation, expand production capacity, and shift toward sustainable sourcing models. EPA (Eicosapentaenoic Acid) and DHA (Docosahexaenoic Acid) are essential omega-3 fatty acids widely used in dietary supplements, infant formula, pharmaceuticals, and functional foods. Recent developments across the industry highlight increasing consolidation, technological advancements, and strategic collaborations aimed at strengthening supply chains and improving product purity and bioavailability.

The market is also witnessing strong momentum in algae-based omega-3 production, regulatory approvals for new formulations, and expanding applications in clinical nutrition and functional beverages. These developments are expected to significantly influence the competitive landscape and growth trajectory through 2034.

Recent News and Industry Developments in EPA & DHA Omega-3 Market

1. Major Industry Consolidation and Acquisitions

One of the most significant recent developments in the EPA & DHA omega-3 industry is the ongoing consolidation among key players. Companies are actively acquiring or merging omega-3 ingredient portfolios to strengthen global supply chains and improve cost efficiency.

• The acquisition of BASF’s food and health performance ingredients business by Louis Dreyfus Company marks a major restructuring in omega-3 production and distribution networks, consolidating high-value omega-3 assets under a single global operator.
• Similarly, KD Pharma Group expanded its position by acquiring parts of dsm-firmenich’s marine lipids business, reinforcing its leadership in pharmaceutical-grade omega-3 production.

These moves indicate a broader industry trend toward vertical integration and supply chain control.

2. Expansion of Algae-Based Omega-3 Production

A key recent trend is the accelerated development of algae-derived EPA & DHA, which is becoming a central focus for sustainability-driven growth.

• Companies such as Aker BioMarine are expanding algae omega-3 solutions in emerging markets, particularly Asia-Pacific, to meet rising demand for plant-based nutrition alternatives.
• In 2025, DSM-Firmenich introduced new algae-based omega-3 ingredients under its Life’sOMEGA portfolio for functional foods and nutraceutical applications.

This shift is driven by increasing consumer preference for vegan, environmentally friendly, and traceable ingredients, reducing dependency on marine fish stocks.

3. Product Innovation and High-Concentration Formulations

Recent years have seen strong innovation in high-potency omega-3 formulations designed to improve absorption, dosage efficiency, and consumer convenience.

• DSM-Firmenich launched highly concentrated DHA oils capable of delivering over 500 mg DHA per serving, enabling smaller capsule sizes and improved bioavailability.
• Epax introduced next-generation omega-3 concentrates with significantly higher levels of very long-chain fatty acids, targeting premium nutraceutical applications.

These innovations are reshaping dietary supplement design, making omega-3 products more effective and easier to consume.

4. Regulatory Approvals and Market Expansion

Regulatory approvals continue to play a key role in expanding global market access for EPA & DHA products.

• Corbion received regulatory clearance in China for its algae-based DHA products, enabling entry into one of the world’s fastest-growing nutraceutical markets.

Such approvals are critical for expanding product availability in infant nutrition, pharmaceuticals, and fortified foods across Asia and other emerging economies.

5. Capacity Expansion and Manufacturing Upgrades

Manufacturers are also investing heavily in production capacity expansion and technological upgrades to meet rising global demand.

• Golden Omega expanded its fish oil processing facility in Chile, increasing EPA and DHA production capacity by approximately 20% through advanced molecular distillation systems.
• GC Rieber introduced new technologies aimed at improving omega-3 purity, stability, and shelf life in commercial formulations.

These investments highlight the industry’s focus on scaling production while maintaining quality standards.

6. Growing Applications in Functional Foods and Infant Nutrition

Recent developments show increasing integration of EPA & DHA into everyday food products.

• Companies are developing omega-3-enriched gummies, beverages, and dairy products to improve consumer accessibility.
• Infant formula manufacturers continue to expand DHA inclusion due to its essential role in brain and eye development.

This expansion beyond traditional supplements is broadening the consumer base significantly.

Download Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00014931

Market Impact of Recent Developments

The latest developments in the EPA & DHA omega-3 market indicate several structural changes:

• Supply chain consolidation is increasing control over raw materials and production efficiency
• Algae-based omega-3 expansion is reducing reliance on fish oil and improving sustainability
• Technological innovation is enhancing product effectiveness and consumer acceptance
• Regulatory approvals are opening new geographic markets, particularly in Asia
• Functional food integration is expanding omega-3 consumption beyond supplements

Together, these trends are reshaping the competitive landscape and accelerating long-term market growth.

Top Players in the Global EPA & DHA Omega-3 Market

The market is moderately consolidated, with leading companies focusing on innovation, sustainability, and global expansion:

• Koninklijke DSM N.V. (dsm-firmenich)
• BASF SE
• Cargill, Incorporated
• Croda International Plc
• Omega Protein Corporation
• Aker BioMarine
• Epax Norway AS
• GC Rieber Oils
• Polaris
• Solutex
• Nordic Naturals
• Lysi

These players are actively investing in algae-based production, pharmaceutical-grade omega-3, and advanced encapsulation technologies to strengthen global competitiveness.

FAQs

Q1. What are the latest trends in the EPA & DHA omega-3 market?
Key trends include algae-based omega-3 expansion, product innovation, industry consolidation, and functional food integration.

Q2. Why is algae-based omega-3 gaining importance?
It is sustainable, vegan-friendly, and reduces dependence on marine fish sources.

Q3. What recent acquisitions are shaping the market?
Major acquisitions involving BASF, dsm-firmenich, and KD Pharma are reshaping global supply chains.

Q4. Which innovations are impacting product development?
High-concentration omega-3 formulations and microencapsulation technologies are key innovations.

Q5. Which region is driving new growth?
Asia Pacific is a major growth region due to rising health awareness and regulatory approvals.

About Us

The Insight Partners is a leading market research and consulting firm providing syndicated and customized research reports across healthcare, food & beverage, chemicals, and consumer goods industries. We deliver actionable insights and strategic intelligence to support global business decision-making.

Contact Us

🌐 Website: https://www.theinsightpartners.com
📧 Email: sales@theinsightpartners.com